Does LENVATINIB Cause Eosinophil count increased? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Eosinophil count increased have been filed in association with LENVATINIB (Lenvima). This represents 0.1% of all adverse event reports for LENVATINIB.
22
Reports of Eosinophil count increased with LENVATINIB
0.1%
of all LENVATINIB reports
0
Deaths
15
Hospitalizations
How Dangerous Is Eosinophil count increased From LENVATINIB?
Of the 22 reports, 15 (68.2%) required hospitalization.
Is Eosinophil count increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENVATINIB. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does LENVATINIB Cause?
Diarrhoea (4,262)
Hypertension (4,152)
Fatigue (3,603)
Decreased appetite (3,257)
Malignant neoplasm progression (2,929)
Nausea (2,492)
Blood pressure increased (2,228)
Vomiting (1,962)
Asthenia (1,643)
Malaise (1,602)
What Other Drugs Cause Eosinophil count increased?
ALBUTEROL (1,359)
PREDNISONE (846)
BUDESONIDE\FORMOTEROL (719)
DUPILUMAB (712)
TIOTROPIUM (682)
MEPOLIZUMAB (670)
MONTELUKAST (504)
BUDESONIDE (493)
CLOZAPINE (475)
FLUTICASONE\SALMETEROL (416)
Which LENVATINIB Alternatives Have Lower Eosinophil count increased Risk?
LENVATINIB vs LEPONEX
LENVATINIB vs LERCANIDIPINE
LENVATINIB vs LETAIRIS
LENVATINIB vs LETERMOVIR
LENVATINIB vs LETROZOLE